rs121912865
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_001844.5(COL2A1):c.2155C>T(p.Arg719Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,612,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R719H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001844.5 missense
Scores
Clinical Significance
Conservation
Publications
- achondrogenesis type IIInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Kniest dysplasiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
- platyspondylic dysplasia, Torrance typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- spondyloepimetaphyseal dysplasia, Strudwick typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- spondyloepiphyseal dysplasia congenitaInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- spondyloepiphyseal dysplasia with metatarsal shorteningInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- spondylometaphyseal dysplasiaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- spondyloperipheral dysplasiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Stickler syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, ClinGen, Illumina, Orphanet, Genomics England PanelApp
- Stickler syndrome, type I, nonsyndromic ocularInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- avascular necrosis of femoral head, primary, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Legg-Calve-Perthes diseaseInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritisInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- otospondylomegaepiphyseal dysplasia, autosomal recessiveInheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- spondyloepiphyseal dysplasia, Stanescu typeInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- autosomal dominant rhegmatogenous retinal detachmentInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dysspondyloenchondromatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial avascular necrosis of femoral headInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypochondrogenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple epiphyseal dysplasia, Beighton typeInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- spondylometaphyseal dysplasia, Schmidt typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- otospondylomegaepiphyseal dysplasiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
- vitreoretinopathy with phalangeal epiphyseal dysplasiaInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL2A1 | NM_001844.5 | c.2155C>T | p.Arg719Cys | missense_variant | Exon 33 of 54 | ENST00000380518.8 | NP_001835.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL2A1 | ENST00000380518.8 | c.2155C>T | p.Arg719Cys | missense_variant | Exon 33 of 54 | 1 | NM_001844.5 | ENSP00000369889.3 | ||
| COL2A1 | ENST00000337299.7 | c.1948C>T | p.Arg650Cys | missense_variant | Exon 32 of 53 | 1 | ENSP00000338213.6 | |||
| COL2A1 | ENST00000483376.1 | n.333C>T | non_coding_transcript_exon_variant | Exon 4 of 8 | 5 | |||||
| COL2A1 | ENST00000493991.5 | n.1079C>T | non_coding_transcript_exon_variant | Exon 16 of 37 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460594Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 726614 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74310 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 719 of the COL2A1 protein (p.Arg719Cys). This variant is present in population databases (rs121912865, gnomAD 0.007%). This missense change has been observed in individual(s) with autosomal dominant osteoarthritis with mild chondrodysplasia or early-onset osteoarthritis (PMID: 1975693, 1985108, 26443184). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg519Cys. ClinVar contains an entry for this variant (Variation ID: 17353). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL2A1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Occurs in the triple helical domain at the Y position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the Y position is not a common mechanism of disease (HGMD); Also known as p.Arg519Cys; This variant is associated with the following publications: (PMID: 37334733, 36142745, 32071555, 11708863, 26443184, 1985108, 37443051, 36682125, 32510848, 1975693, 32901917)
Namaqualand hip dysplasia Pathogenic:2
This variant (sometimes referred to as p.Arg519Cys in older literature) is very rare in the general population and has been identified in several other families with a similar phenotype (PMID: 16155195, 1975693, 1985108, 26443184). Type II collagen is a major constituent of articular cartilage. The variant leads to substitution of an Arginine with a Cysteine molecule in the triple helix domain of type II collagen. Functional studies suggest that this leads to abnormal assembly of type II collagen fibrils (PMID: 10372559).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at